SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News:
January – March 2011
* Net sales rose by 24% to SEK 22.2m (17.8). Adjusted for currency fluctuations, net sales rose by 38% * Sales of NIOX MINO® refill tests rose in total by 48% and in the US sales of repeat tests for clinical use rose by 135% * The loss after tax amounted to SEK 26.9m (28.7), corresponding to a loss per share before dilution of SEK 0.3 (0.4) * The German superior court has confirmed the ruling by the federal court that Medisoft is in infringement of two of Aerocrine’s patents. A ruling regarding Medisoft’s appeal of its infringement of a third Aerocrine patent will be forthcoming. The federal patent court in Munich recently issued a ruling where this Aerocrine patent was found to be valid * Aerocrine acquires all assets related to FENO testing from FILT GmbH and initiates cooperation on technical development
